ZEE Business
ZEE BUSINESS
हिंदी में पढ़ें  हिंदी में पढ़ें
Live TV
Live TV
  • Home
  • Personal Finance
    • PPF
    • Mutual Funds
    • Income tax
    • EPFO
    • Income Tax Calculator
    • Personal Loan Calculator
    • Car Loan Calculator
    • Home Loan Calculator
    • SIP calculator
    • SWP Calculator
    • MF Returns Calculator
    • Lumpsum Calculator
  • India
    • Companies
    • Property
    • Startups
    • Uidai
  • Economy
    • Aviation
  • Tech
    • Mobiles
    • Apps
  • Auto
    • Cars
    • Bikes
  • Markets
    • Commodities
    • Currency
  • Railways
  • World
    • Economy
    • Politics
    • Markets
  • Survey
  • videos
  • photos
  • More ...
    • VIDEOS
    • PHOTOS
BREAKING NEWS
  • Market ends with marginal cuts this week; FMCG gains, Consumer Durables decline—What should investors do on Monday?
  • Investors with short term view must book profits now; import duty hike, rupee weakness may arrest price correction, temporarily
  • Virtual Digital Assets: VDAs to attract 1% TDS from today; know what CBDT says about new norms
  • Maruti Suzuki, Ashok Leyland: What makes brokerages bullish on these auto stocks?
  • Monsoon session of Parliament to begin on July 18; to end on August 12
Read in App
Business News » World News

Lilly cancer drug fails key trial, will no longer be prescribed

  • Twitter
  • Facebook
  • Linkedin
  • whatapp
  • View in App

Eli Lilly and Co said on Friday that its cancer treatment Lartruvo, which had won conditional approval, failed to improve patient survival in a long-term confirmatory study and will no longer be prescribed, driving the drugmaker`s shares down nearly 3 percent.

No new U.S. patients will be started on the drug and Lilly is suspending promotion of the medicine, the company said.

Lartruvo won accelerated approval in 2016 in the United States and conditional approval in Europe based on results from a promising mid-stage trial. But its continued approval was contingent on the results of a larger, late-stage trial confirming the drug`s benefits.

On Friday, Lilly said Lartruvo combined with the standard-of-care chemotherapy doxorubicin did not prolong survival more than doxorubicin alone in patients with advanced soft tissue sarcoma.

Lilly oncology chief Anne White said in a phone interview the results were "completely unexpected."

The disappointing outcome reflects the risk involved when drugs are approved based on smaller trials with promising data.

"In a sense, this is the way it`s supposed to work," White said. "You do that confirmatory study. Obviously, there are times when it doesn`t work out."

Lartruvo will continue to be available to patients who appear to be benefiting from it as global regulators determine the next steps for the treatment, White said.

The Lartruvo news is a major setback to Lilly`s efforts to significantly boost its presence in oncology, as evidenced by its announcement last week that it would buy Loxo Oncology Inc for $8 billion to acquire its cancer drugs that target rare genetic mutations.

Analysts had forecast 2019 Lartruvo sales of $374.50 million, according to IBES data from Refinitiv.

Lilly in the past had avoided large deals, preferring to develop its own drugs. But the Loxo deal, the biggest acquisition in Lilly`s 143-year history, followed last year`s $1.6 billion purchase of Armo Biosciences, a developer of immunotherapy drugs.

"Given Lilly`s strategic focus on oncology, this increases the probability that Lilly will make more oncology acquisitions to improve scale," BMO Capital Markets analyst Alex Arfaei said of the Lartruvo setback in a research note.

Lilly expects to take a first-quarter pretax charge of $70 million to $90 million, or about 10 cents per share, after tax, and said the setback will cut about 17 cents per share from its full-year 2019 earnings forecast.

The company does not see a change in its 2020 minimum financial goals.

Eli Lilly shares were down 2.8 percent at $115.81 afternoon trading.

(This article has not been edited by Zeebiz editorial team and is auto-generated from an agency feed.)

Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.

TAGS:
Economy
Updated: Sat, Jan 19, 2019
12:45 am
Reuters
RELATED NEWS
Crisil cuts FY23 GDP growth estimate to 7.3% Crisil cuts FY23 GDP growth estimate to 7.3%
US stocks see worst first half drop in over 50 years US stocks see worst first half drop in over 50 years
Rupee hits record low of 79.11 against US dollar in early trade Rupee hits record low of 79.11 against US dollar in early trade
Retail inflation for industrial workers rises to 6.97% in May Retail inflation for industrial workers rises to 6.97% in May
GST Council Meeting: Full details of goods and services, where rates hiked or slashed GST Council Meeting: Full details of goods and services, where rates hiked or slashed

LATEST NEWS

Oil India Limited completes beta demo of hydrogen powered bus developed under its Startup programme SNEH

Stocks to Buy: Sanjiv Bhasin recommends Aarti Industries, Bank of Baroda, Tata Steel; Know the details

Stocks to Buy: Vikas Sethi recommends IDFC from F&O, Indo count from Cash Market; know why?

India's June factory growth at 9-month low as inflation worries bite

LPG Cylinder Price: 19-kg commercial cylinder gets cheaper by nearly Rs 200; check rates in other Metro cities

Food labelling rules for online food delivery platforms like Zomato, Swiggy changed from today; compliance failure to invite action

Dalal Street Corner: Market ends with marginal cuts this week; FMCG gains, Consumer Durables decline—What should investors do on Monday?

Gold Price Today: Investors with short term view must book profits now; import duty hike, rupee weakness may arrest price correction, temporarily

Opening Bell: Nifty slips below 15,700, Sensex sheds over 350 points; Auto, Consumer Durables worst hit

IBPS Clerk Recruitment 2022: Registration begins for 6000+ vacancies at ibps.in; check direct link, last date, how to apply online and more

  • India News
  • World News
  • Companies News
  • Market News
  • Personal Finance News
  • Technology News
  • Automobile News
  • Small Business News
  • Income Tax Calculator
  • Live TV
  • Videos
  • Photos
  • Author
  • Rss Feed
  • Advertise with us
  • Privacy Policy
  • Legal Disclaimer

Latest Trending Updates

  • EPFO
  • Budget 2020
  • Income Tax Return
  • Auto Expo 2020
  • Home Loan
  • Business News

Trending Topics

  • Income Tax
  • income Tax Calculator
  • 7th Pay Commission
  • Reserve Bank of India
  • GST
  • Latest Business News

Follow us on

zeebiz
zeebiz

Partner Sites

  • Zee News
  • Hindi News
  • Marathi News
  • Bengali News
  • Tamil News
  • Malayalam News
  • Gujarati News
  • Telugu News
  • Kannada News
  • DNA
  • WION
© 2022. India Dot Com Private Limited. All Rights Reserved.
LIVE TV